{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,12]],"date-time":"2025-10-12T02:28:54Z","timestamp":1760236134071,"version":"build-2065373602"},"reference-count":128,"publisher":"MDPI AG","issue":"21","license":[{"start":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:00:00Z","timestamp":1635379200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["IJMS"],"abstract":"<jats:p>The renin\u2013angiotensin system (RAS) is a key regulator of blood pressure and hypertension. Angiotensin-converting enzyme 2 (ACE2) and angiotensin-converting enzyme I (ACE) are two main components of the RAS that play a major role in blood pressure homeostasis. The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) uses ACE2 as a receptor to enter cells. Despite some controversies, numerous studies have reported a significant association between the use of ACE inhibitors and reduced risk of COVID-19. In our previous studies, we produced and identified peptide sequences present in whey hydrolysates exhibiting high ACE inhibitory activity. Therefore, the aim of this work is to obtain an improved understanding of the function of these natural peptides as RAS inhibitors and investigate their potential therapeutic role in the COVID-19 pandemic. The molecular interactions between peptides IPP, LIVTQ, IIAE, LVYPFP, and human ACE2 were assessed by employing a molecular docking approach. The results show that natural whey-derived peptides have a dual inhibitory action against both ACE and ACE2. This dual activity distinguishes these ACE inhibitory peptides from synthetic drugs, such as Captopril and Lisinopril which were not shown to inhibit ACE2 activity, and may represent a potential strategy in the treatment of COVID-19.<\/jats:p>","DOI":"10.3390\/ijms222111662","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T23:51:36Z","timestamp":1635465096000},"page":"11662","update-policy":"https:\/\/doi.org\/10.3390\/mdpi_crossmark_policy","source":"Crossref","is-referenced-by-count":7,"title":["Whey-Derived Peptides at the Heart of the COVID-19 Pandemic"],"prefix":"10.3390","volume":"22","author":[{"given":"Yara","family":"Chamata","sequence":"first","affiliation":[{"name":"Harry Nursten Building, Department of Food and Nutritional Sciences, University of Reading, Reading RG6 6DZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0070-3203","authenticated-orcid":false,"given":"Kim G.","family":"Jackson","sequence":"additional","affiliation":[{"name":"Harry Nursten Building, Department of Food and Nutritional Sciences, University of Reading, Reading RG6 6DZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9987-8539","authenticated-orcid":false,"given":"Kimberly A.","family":"Watson","sequence":"additional","affiliation":[{"name":"Health and Life Sciences Building, School of Biological Sciences, University of Reading, Reading RG6 6EX, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula","family":"Jauregi","sequence":"additional","affiliation":[{"name":"Harry Nursten Building, Department of Food and Nutritional Sciences, University of Reading, Reading RG6 6DZ, UK"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1968","published-online":{"date-parts":[[2021,10,28]]},"reference":[{"key":"ref_1","unstructured":"World Health Organization (WHO) (2021, June 20). Cardiovascular Diseases (CVDs): Key Facts. Available online: https:\/\/www.who.int\/news-room\/factsheets\/detail\/cardiovascular-diseases-(cvds)."},{"key":"ref_2","unstructured":"Townsend, N.W.J., Bhatnagar, P., Wickramasinghe, K., and Rayner, M. (2014). Cardiovascular Disease Statistics, 2014, British Heart Foundation."},{"key":"ref_3","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1038\/s41581-019-0244-2","article-title":"The global epidemiology of hypertension","volume":"16","author":"Mills","year":"2020","journal-title":"Nat. Rev. Nephrol."},{"key":"ref_4","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s40292-015-0120-5","article-title":"Role of the renin-angiotensin-aldosterone system and its pharmacological inhibitors in cardiovascular diseases: Complex and critical issues","volume":"22","author":"Borghi","year":"2015","journal-title":"High Blood Press. Cardiovasc. Prev."},{"key":"ref_5","doi-asserted-by":"crossref","first-page":"H137","DOI":"10.1152\/ajpheart.00618.2015","article-title":"Biochemical evaluation of the renin-angiotensin system: The good, bad, and absolute?","volume":"310","author":"Chappell","year":"2016","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_6","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.87.6.1816","article-title":"Molecular biology of the renin-angiotensin system","volume":"87","author":"Griendling","year":"1993","journal-title":"Circulation"},{"key":"ref_7","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/nrd1227","article-title":"Ace revisited: A new target for structure-based drug design","volume":"2","author":"Acharya","year":"2003","journal-title":"Nat. Rev. Drug Discov."},{"key":"ref_8","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0271-5317(04)00058-2","article-title":"Angiotensin I\u2013converting enzyme inhibitory peptides derived from food proteins and their physiological and pharmacological effects","volume":"24","author":"Li","year":"2004","journal-title":"Nutr. Res."},{"key":"ref_9","doi-asserted-by":"crossref","first-page":"9002","DOI":"10.1016\/S0021-9258(18)31543-6","article-title":"The two homologous domains of human angiotensin I-converting enzyme are both catalytically active","volume":"266","author":"Wei","year":"1991","journal-title":"J. Biol. Chem."},{"key":"ref_10","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.1007\/s00018-004-4239-0","article-title":"Structure of angiotensin I-converting enzyme","volume":"61","author":"Sturrock","year":"2004","journal-title":"Cell. Mol. Life Sci."},{"key":"ref_11","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1210\/er.2003-0001","article-title":"Newly Recognized Components of the Renin-Angiotensin System: Potential Roles in Cardiovascular and Renal Regulation","volume":"24","author":"Carey","year":"2003","journal-title":"Endocr. Rev."},{"key":"ref_12","first-page":"551","article-title":"Crystal structure of the human angiotensin-converting enzyme\u2013lisinopril complex","volume":"421","author":"Natesh","year":"2003","journal-title":"Nat. Cell Biol."},{"key":"ref_13","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/protein\/gzg122","article-title":"Structure\u2013function discrimination of the N-and C-catalytic domains of human angiotensin-converting enzyme: Implications for Cl\u2013activation and peptide hydrolysis mechanisms","volume":"16","author":"Tzakos","year":"2003","journal-title":"Protein Eng."},{"key":"ref_14","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1007\/s11906-011-0187-x","article-title":"Cell Signaling of Angiotensin II on Vascular Tone: Novel Mechanisms","volume":"13","author":"Cat","year":"2011","journal-title":"Curr. Hypertens. Rep."},{"key":"ref_15","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00424-012-1146-3","article-title":"AT2 receptors: Beneficial counter-regulatory role in cardiovascular and renal function","volume":"465","author":"Padia","year":"2013","journal-title":"Pfl\u00fcgers Archiv-Eur. J. Physiol."},{"key":"ref_16","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.113.01274","article-title":"Angiotensin-(1\u20137)","volume":"63","author":"Santos","year":"2014","journal-title":"Hypertension"},{"key":"ref_17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2012\/256294","article-title":"Angiotensin-Converting Enzyme 2 (ACE2) Is a Key Modulator of the Renin Angiotensin System in Health and Disease","volume":"2012","author":"Tikellis","year":"2012","journal-title":"Int. J. Pept."},{"key":"ref_18","doi-asserted-by":"crossref","first-page":"E1","DOI":"10.1161\/01.RES.87.5.e1","article-title":"A Novel Angiotensin-Converting Enzyme\u2013Related Carboxypeptidase (ACE2) Converts Angiotensin I to Angiotensin 1\u20139","volume":"87","author":"Donoghue","year":"2000","journal-title":"Circ. Res."},{"key":"ref_19","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1042\/BJ20040634","article-title":"Evaluation of angiotensin-converting enzyme (ACE), its homologue ACE2 and neprilysin in angiotensin peptide metabolism","volume":"383","author":"Rice","year":"2004","journal-title":"Biochem. J."},{"key":"ref_20","doi-asserted-by":"crossref","first-page":"14838","DOI":"10.1074\/jbc.M200581200","article-title":"Hy-Drolysis of Biological Peptides by Human Angiotensin-Converting Enzyme-Related Carboxypep-Tidase","volume":"277","author":"Vickers","year":"2002","journal-title":"J. Biol. Chem."},{"key":"ref_21","doi-asserted-by":"crossref","first-page":"8258","DOI":"10.1073\/pnas.1432869100","article-title":"Angiotensin-(1\u20137) is an endogenous ligand for the G protein-coupled receptor Mas","volume":"100","author":"Santos","year":"2003","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_22","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1590\/S0100-879X2002000900009","article-title":"Angiotensin-(1\u20137) improves the post-ischemic function in isolated perfused rat hearts","volume":"35","author":"Ferreira","year":"2002","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_23","doi-asserted-by":"crossref","unstructured":"D\u2019Ardes, D., Boccatonda, A., Rossi, I., Guagnano, M.T., Santilli, F., Cipollone, F., and Bucci, M. (2020). COVID-19 and RAS: Unravelling an Unclear Relationship. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21083003"},{"key":"ref_24","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1590\/S0100-879X2005000400003","article-title":"Cardiovascular actions of angiotensin-(1-7)","volume":"38","author":"Ferreira","year":"2005","journal-title":"Braz. J. Med. Biol. Res."},{"key":"ref_25","unstructured":"World Health Organization (2021, October 14). Coronavirus Disease (COVID-19) Outbreak Situation. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019."},{"key":"ref_26","doi-asserted-by":"crossref","unstructured":"Coronaviridae Study Group of the International Committee on Taxonomy of Viruses (2020). The Species Severe Acute Respiratory Syndrome-Related Coronavirus: Classifying 2019-NCoV and Naming It SARS-CoV-2. Nat. Microbiol., 5, 536\u2013544.","DOI":"10.1038\/s41564-020-0695-z"},{"key":"ref_27","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/s41579-018-0118-9","article-title":"Origin and evolution of pathogenic coronaviruses","volume":"17","author":"Cui","year":"2019","journal-title":"Nat. Rev. Microbiol."},{"key":"ref_28","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1056\/NEJMoa2001017","article-title":"A Novel Coronavirus from Patients with Pneumonia in China, 2019","volume":"382","author":"Zhu","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_29","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1016\/S0140-6736(20)30251-8","article-title":"Genomic Characterisa-Tion and Epidemiology of 2019 Novel Coronavirus: Implications for Virus Origins and Receptor Binding","volume":"395","author":"Lu","year":"2020","journal-title":"Lancet"},{"key":"ref_30","doi-asserted-by":"crossref","first-page":"81","DOI":"10.46234\/ccdcw2020.023","article-title":"Description of the First Strain of 2019-NCoV, C-Tan-NCoV Wuhan Strain\u2014National Pathogen Resource Center, China, 2020","volume":"2","author":"Wei","year":"2020","journal-title":"China CDC Wkly."},{"key":"ref_31","doi-asserted-by":"crossref","unstructured":"Wu, F., Zhao, S., Yu, B., Chen, Y.-M., Wang, W., Hu, Y., Song, Z.-G., Tao, Z.-W., Tian, J.-H., and Pei, Y.-Y. (2020). Complete genome characterisation of a novel coronavirus associated with severe human respiratory disease in Wuhan, China. bioRxiv.","DOI":"10.1101\/2020.01.24.919183"},{"key":"ref_32","doi-asserted-by":"crossref","first-page":"102433","DOI":"10.1016\/j.jaut.2020.102433","article-title":"The epidemiology and pathogenesis of coronavirus disease (COVID-19) outbreak","volume":"109","author":"Rothan","year":"2020","journal-title":"J. Autoimmun."},{"key":"ref_33","doi-asserted-by":"crossref","unstructured":"Tortorici, M.A., and Veesler, D. (2019). Structural Insights into Coronavirus Entry, Elsevier Inc.","DOI":"10.1016\/bs.aivir.2019.08.002"},{"key":"ref_34","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1126\/science.abb2507","article-title":"Cryo-EM Structure of the 2019-NCoV Spike in the Prefusion Confor-Mation","volume":"367","author":"Wrapp","year":"2020","journal-title":"Science"},{"key":"ref_35","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1126\/science.abc1669","article-title":"SARS-CoV-2 Productively Infects Human Gut Enterocytes","volume":"369","author":"Lamers","year":"2020","journal-title":"Science"},{"key":"ref_36","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1159\/000507305","article-title":"Should COVID-19 Concern Nephrologists? Why and to What Extent? The Emerging Impasse of Angiotensin Blockade","volume":"144","author":"Perico","year":"2020","journal-title":"Nephron"},{"key":"ref_37","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: A retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"ref_38","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 Cell Entry Depends on ACE2 and TMPRSS2 and Is Blocked by a Clinically Proven Protease Inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"ref_39","doi-asserted-by":"crossref","first-page":"4825","DOI":"10.1111\/bph.15082","article-title":"A hypothesis for pathobiology and treatment of COVID-19: The centrality of ACE1 \/ ACE2 imbalance","volume":"177","author":"Sriram","year":"2020","journal-title":"Br. J. Pharmacol."},{"key":"ref_40","doi-asserted-by":"crossref","unstructured":"Saadah, L.M., Abu Deiab, G.I., Al-Balas, Q., and Basheti, I.A. (2020). Carnosine to Combat Novel Coronavirus (nCoV): Molecular Docking and Modeling to Cocrystallized Host Angiotensin-Converting Enzyme 2 (ACE2) and Viral Spike Protein. Molecules, 25.","DOI":"10.3390\/molecules25235605"},{"key":"ref_41","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.ijbiomac.2020.07.174","article-title":"A molecular docking study revealed that synthetic peptides induced conformational changes in the structure of SARS-CoV-2 spike glycoprotein, disrupting the interaction with human ACE2 receptor","volume":"164","author":"Souza","year":"2020","journal-title":"Int. J. Biol. Macromol."},{"key":"ref_42","doi-asserted-by":"crossref","first-page":"11171","DOI":"10.7717\/peerj.11171","article-title":"A Molecular Dynamics Simula-Tion Study of the ACE2 Receptor with Screened Natural Inhibitors to Identify Novel Drug Candi-Date against COVID-19","volume":"9","author":"Srivastava","year":"2021","journal-title":"PeerJ"},{"key":"ref_43","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1161\/01.HYP.0000237862.94083.45","article-title":"Enalapril Attenuates Downregulation of Angiotensin-Converting Enzyme 2 in the Late Phase of Ventricular Dysfunction in Myocardial Infarcted Rat","volume":"48","author":"Ocaranza","year":"2006","journal-title":"Hypertension"},{"key":"ref_44","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMra032498","article-title":"The Severe Acute Respiratory Syndrome","volume":"349","author":"Peiris","year":"2003","journal-title":"N. Engl. J. Med."},{"key":"ref_45","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1038\/nm1267","article-title":"A crucial role of angiotensin converting enzyme 2 (ACE2) in SARS coronavirus\u2013induced lung injury","volume":"11","author":"Kuba","year":"2005","journal-title":"Nat. Med."},{"key":"ref_46","first-page":"E014","article-title":"Inhibitors of RAS might be a good choice for the therapy of COVID-19 pneumonia","volume":"43","author":"Sun","year":"2020","journal-title":"Chin. J. Tuberc. Respir. Dis."},{"key":"ref_47","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1007\/s00726-014-1889-6","article-title":"Human Intestine Luminal ACE2 and Amino Acid Trans-Porter Expression Increased by ACE-Inhibitors","volume":"47","author":"Camargo","year":"2015","journal-title":"Amino Acids"},{"key":"ref_48","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41569-020-0360-5","article-title":"COVID-19 and the cardiovascular system","volume":"17","author":"Zheng","year":"2020","journal-title":"Nat. Rev. Cardiol."},{"key":"ref_49","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1093\/eurheartj\/ehaa235","article-title":"SARS-CoV2: Should Inhibitors of the Renin-Angiotensin System Be Withdrawn in Patients with COVID-19?","volume":"41","author":"Kuster","year":"2020","journal-title":"Eur. Heart J."},{"key":"ref_50","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1002\/ejhf.1871","article-title":"COVID- 19 and heart failure: From infection to inflammation and angiotensin II stimulation. Searching for evidence from a new disease","volume":"22","author":"Tomasoni","year":"2020","journal-title":"Eur. J. Heart Fail."},{"key":"ref_51","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1161\/CIRCULATIONAHA.104.510461","article-title":"Effect of Angiotensin-Converting Enzyme Inhibition and Angiotensin II Receptor Blockers on Cardiac Angiotensin-Converting Enzyme 2","volume":"111","author":"Ferrario","year":"2005","journal-title":"Circulation"},{"key":"ref_52","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are Patients with Hypertension and Diabetes Mellitus at Increased Risk for COVID-19 Infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir. Med."},{"key":"ref_53","doi-asserted-by":"crossref","first-page":"H1084","DOI":"10.1152\/ajpheart.00217.2020","article-title":"COVID-19, ACE2, and the cardiovascular consequences","volume":"318","author":"South","year":"2020","journal-title":"Am. J. Physiol. Circ. Physiol."},{"key":"ref_54","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s40635-015-0044-3","article-title":"Angiotensin-(1\u20137) improves oxygenation, while reducing cellular infiltrate and fibrosis in experimental Acute Respiratory Distress Syndrome","volume":"3","author":"Zambelli","year":"2015","journal-title":"Intensiv. Care Med. Exp."},{"key":"ref_55","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin IIreceptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol."},{"key":"ref_56","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of Inpatient Use of Angiotensin-Converting Enzyme Inhibitors and Angiotensin II Receptor Blockers With Mortality Among Patients With Hypertension Hospitalized With COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ. Res."},{"key":"ref_57","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1136\/heartjnl-2020-317393","article-title":"Risk of severe COVID-19 disease with ACE inhibitors and angiotensin receptor blockers: Cohort study including 8.3 million people","volume":"106","author":"Young","year":"2020","journal-title":"Heart"},{"key":"ref_58","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/s41422-020-00450-0","article-title":"Dalbavancin Binds ACE2 to Block Its Interaction with SARS-CoV-2 Spike Protein and Is Effec-Tive in Inhibiting SARS-CoV-2 Infection in Animal Models","volume":"31","author":"Wang","year":"2021","journal-title":"Cell Res."},{"key":"ref_59","doi-asserted-by":"crossref","first-page":"173759","DOI":"10.1016\/j.ejphar.2020.173759","article-title":"Flavonols as Potential Antiviral Drugs Targeting SARS-CoV-2 Proteases (3CLpro and PLpro), Spike Protein, RNA-Dependent RNA Polymerase (RdRp) and Angiotensin-Converting Enzyme II Receptor (ACE2)","volume":"891","author":"Mouffouk","year":"2021","journal-title":"Eur. J. Pharmacol."},{"key":"ref_60","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1128\/AAC.01152-12","article-title":"A Rationally Engineered Anti-HIV Peptide Fusion Inhibitor with Greatly Reduced Immu-Nogenicity","volume":"57","author":"Brauer","year":"2013","journal-title":"Antimicrob. Agents Chemother."},{"key":"ref_61","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.addr.2020.11.007","article-title":"Peptide and Peptide-Based Inhibitors of SARS-CoV-2 Entry","volume":"167","author":"Kirchhoff","year":"2020","journal-title":"Adv. Drug Deliv. Rev."},{"key":"ref_62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.virol.2006.01.029","article-title":"Identification of Critical Determinants on ACE2 for SARS-CoV Entry and Development of a Potent Entry Inhibitor","volume":"350","author":"Han","year":"2006","journal-title":"Virology"},{"key":"ref_63","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1039\/c2fo10192k","article-title":"Antihypertensive peptides from food proteins: A review","volume":"3","author":"Miralles","year":"2012","journal-title":"Food Funct."},{"key":"ref_64","doi-asserted-by":"crossref","unstructured":"Giromini, C., Fekete, \u00c1.A., Givens, D.I., Baldi, A., and Lovegrove, J.A. (2017). Short-Communication: A Comparison of the In Vitro Angiotensin-1-Converting Enzyme Inhibitory Capacity of Dairy and Plant Protein Supplements. Nutrients, 9.","DOI":"10.3390\/nu9121352"},{"key":"ref_65","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.3945\/ajcn.116.137919","article-title":"Whey Protein Lowers Blood Pressure and Improves Endothelial Function and Lipid Biomarkers in Adults with Prehypertension and Mild Hypertension: Results from the Chronic Whey2Go Ran-Domized Controlled Trial","volume":"104","author":"Fekete","year":"2016","journal-title":"Am. J. Clin. Nutr."},{"key":"ref_66","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1017\/S0954422413000139","article-title":"The Impact of Milk Proteins and Pep-Tides on Blood Pressure and Vascular Function: A Review of Evidence from Human Intervention Studies","volume":"26","author":"Fekete","year":"2013","journal-title":"Nutr. Res. Rev."},{"key":"ref_67","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/j.foodchem.2012.03.113","article-title":"Chemical characterisation and determination of sensory attributes of hydrolysates produced by enzymatic hydrolysis of whey proteins following a novel integrative process","volume":"134","author":"Welderufael","year":"2012","journal-title":"Food Chem."},{"key":"ref_68","doi-asserted-by":"crossref","unstructured":"Chamata, Y., Watson, K.A., and Jauregi, P. (2020). Whey-Derived Peptides Interactions with ACE by Molecular Docking as a Potential Predictive Tool of Natural ACE Inhibitors. Int. J. Mol. Sci., 21.","DOI":"10.3390\/ijms21030864"},{"key":"ref_69","doi-asserted-by":"crossref","first-page":"17996","DOI":"10.1074\/jbc.M311191200","article-title":"ACE2 X-Ray Structures Reveal a Large Hinge-bending Motion Important for Inhibitor Binding and Catalysis","volume":"279","author":"Towler","year":"2004","journal-title":"J. Biol. Chem."},{"key":"ref_70","doi-asserted-by":"crossref","first-page":"13185","DOI":"10.1021\/bi035268s","article-title":"Angiotensin-Converting Enzyme-2 (ACE2): Comparative Modeling of the Active Site, Specificity Requirements, and Chloride Dependence","volume":"42","author":"Guy","year":"2003","journal-title":"Biochemistry"},{"key":"ref_71","doi-asserted-by":"crossref","first-page":"107697","DOI":"10.1016\/j.jmgm.2020.107697","article-title":"Prioritizing potential ACE2 inhibitors in the COVID-19 pandemic: Insights from a molecular mechanics-assisted structure-based virtual screening experiment","volume":"100","author":"Baddal","year":"2020","journal-title":"J. Mol. Graph. Model."},{"key":"ref_72","doi-asserted-by":"crossref","first-page":"3512","DOI":"10.1111\/j.1742-4658.2005.04756.x","article-title":"Identification of critical active-site residues in angiotensin-converting enzyme-2 (ACE2) by site-directed mutagenesis","volume":"272","author":"Guy","year":"2005","journal-title":"FEBS J."},{"key":"ref_73","doi-asserted-by":"crossref","first-page":"1795","DOI":"10.1007\/s11030-020-10159-2","article-title":"Identification of novel inhibitors of angiotensin-converting enzyme 2 (ACE-2) receptor from Urtica dioica to combat coronavirus disease 2019 (COVID-19)","volume":"25","author":"Upreti","year":"2021","journal-title":"Mol. Divers."},{"key":"ref_74","doi-asserted-by":"crossref","first-page":"777","DOI":"10.3168\/jds.S0022-0302(95)76689-9","article-title":"Purification and Characterization of Angiotensin I-Converting Enzyme Inhibitors from Sour Milk","volume":"78","author":"Nakamura","year":"1995","journal-title":"J. Dairy Sci."},{"key":"ref_75","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.21873\/invivo.11949","article-title":"Potential Antiviral Drugs for SARS-Cov-2 Treatment: Preclinical Findings and Ongoing Clinical Research","volume":"34","author":"Bimonte","year":"2020","journal-title":"In Vivo"},{"key":"ref_76","unstructured":"(2021, July 24). Centers for Disease Control and Protection, Largest CDC COVID-19 Vaccine Effectiveness Study in Health Workers Shows mRNA Vaccines 94% Effective, Available online: https:\/\/www.cdc.gov\/media\/releases\/2021\/p0514-covid-19-vaccine-effectiveness.htmlhttps:\/\/www.cdc.gov\/media\/releases\/2021\/p0514-covid-19-vaccine-effectiveness.html."},{"key":"ref_77","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s10654-020-00671-y","article-title":"Vaccine hesitancy: The next challenge in the fight against COVID-19","volume":"35","author":"Dror","year":"2020","journal-title":"Eur. J. Epidemiol."},{"key":"ref_78","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/s13063-017-2427-0","article-title":"Treatment of Middle East Respiratory Syndrome with a combination of lopinavir-ritonavir and interferon-\u03b21b (MIRACLE trial): Study protocol for a randomized controlled trial","volume":"19","author":"Arabi","year":"2018","journal-title":"Trials"},{"key":"ref_79","unstructured":"(2021, July 24). COVID-19 Mythbusters\u2014World Health Organization. Available online: https:\/\/www.who.int\/emergencies\/diseases\/novel-coronavirus-2019\/advice-for-public\/myth-busters."},{"key":"ref_80","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/j.sjbs.2015.06.005","article-title":"Milk derived bioactive peptides and their impact on human health\u2014A review","volume":"23","author":"Mohanty","year":"2016","journal-title":"Saudi J. Biol. Sci."},{"key":"ref_81","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S0924-2244(01)00003-6","article-title":"Bioactive peptides derived from bovine whey proteins: Opioid and ace-inhibitory peptides","volume":"11","year":"2000","journal-title":"Trends Food Sci. Technol."},{"key":"ref_82","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1056\/NEJMsr2005760","article-title":"Renin-Angiotensin-Aldosterone System Inhibitors in Patients with Covid-19","volume":"382","author":"Vaduganathan","year":"2020","journal-title":"N. Engl. J. Med."},{"key":"ref_83","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1111\/jcpt.13246","article-title":"Use of Inhibitors of the Renin-Angiotensin System in Hypertensive Patients and COVID-19 Severity: A Systematic Review and Meta-Analysis","volume":"45","author":"Barochiner","year":"2020","journal-title":"J. Clin. Pharm. Ther."},{"key":"ref_84","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1001\/jamainternmed.2020.0994","article-title":"Risk Factors Associated With Acute Respiratory Distress Syndrome and Death in Patients With Coronavirus Disease 2019 Pneumonia in Wuhan, China","volume":"180","author":"Wu","year":"2020","journal-title":"JAMA Intern. Med."},{"key":"ref_85","doi-asserted-by":"crossref","first-page":"e016509","DOI":"10.1161\/JAHA.120.016509","article-title":"Coronavirus Disease 2019 (COVID-19): Do Angiotensin-Converting Enzyme Inhibitors\/Angiotensin Receptor Blockers Have a Biphasic Effect?","volume":"9","author":"Sommerstein","year":"2020","journal-title":"J. Am. Heart Assoc."},{"key":"ref_86","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1097\/SHK.0b013e3180310f3a","article-title":"Angiotensin-converting enzyme inhibitor captopril prevents oleic acid-induced severe acute lung injury in rats","volume":"28","author":"He","year":"2007","journal-title":"Shock"},{"key":"ref_87","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1161\/HYPERTENSIONAHA.120.15082","article-title":"Renin-Angiotensin System Blockers and the COVID-19 Pandemic: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers: At Present There Is No Evidence to Abandon Renin-Angiotensin System Blockers","volume":"75","author":"Danser","year":"2020","journal-title":"Hypertension"},{"key":"ref_88","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1002\/ppul.20187","article-title":"Angiotensin II Receptor Inhibition Prevents Pneumocyte Apoptosis in Surfactant-Depleted Rat Lungs: Apoptosis in Surfactant Depleted-Lungs","volume":"39","author":"Lukkarinen","year":"2005","journal-title":"Pediatr. Pulmonol."},{"key":"ref_89","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1440-1843.2011.02092.x","article-title":"Radiation Damage to the Lung: Mitigation by Angiotensin-Converting Enzyme (ACE) Inhibitors: Radiation Lung Damage and Mitigation","volume":"17","author":"Medhora","year":"2012","journal-title":"Respirology"},{"key":"ref_90","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.ijrobp.2011.05.081","article-title":"Mitigation of Late Renal and Pulmonary Injury After Hematopoietic Stem Cell Transplantation","volume":"83","author":"Cohen","year":"2012","journal-title":"Int. J. Radiat. Oncol."},{"key":"ref_91","doi-asserted-by":"crossref","first-page":"e4260","DOI":"10.1136\/bmj.e4260","article-title":"Risk of pneumonia associated with use of angiotensin converting enzyme inhibitors and angiotensin receptor blockers: Systematic review and meta-analysis","volume":"345","author":"Caldeira","year":"2012","journal-title":"BMJ"},{"key":"ref_92","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1093\/cid\/cis733","article-title":"Population-Based Study of Statins, Angiotensin II Receptor Blockers, and Angiotensin-Converting Enzyme Inhibitors on Pneumonia-Related Outcomes","volume":"55","author":"Mortensen","year":"2012","journal-title":"Clin. Infect. Dis."},{"key":"ref_93","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1042\/CS20120081","article-title":"Renin\u2013angiotensin system blockade: A novel therapeutic approach in chronic obstructive pulmonary disease","volume":"123","author":"Shrikrishna","year":"2012","journal-title":"Clin. Sci."},{"key":"ref_94","doi-asserted-by":"crossref","first-page":"e643","DOI":"10.1016\/j.prro.2015.07.003","article-title":"Angiotensin-converting enzyme inhibitors decrease the risk of radiation pneumonitis after stereotactic body radiation therapy","volume":"5","author":"Harder","year":"2015","journal-title":"Pr. Radiat. Oncol."},{"key":"ref_95","unstructured":"(2021, May 20). ESH STATEMENT ON COVID-19|European Society of Hypertension. Available online: https:\/\/www.eshonline.org\/esh-content\/uploads\/2020\/06\/Statement-ESH-on-Hypertension-RAS-Blockers-and-COVID-19-Update-April-15-2020.pdf."},{"key":"ref_96","unstructured":"(2021, May 20). Position Statement of the ESC Council on Hypertension on ACE-Inhibitors and Angiotensin Receptor Blockers. Available online: https:\/\/www.sphta.org.pt\/files\/european_society_of_hypertension_-_statement_on_covid-19.pdf."},{"key":"ref_97","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1016\/j.cardfail.2020.04.013","article-title":"Joint HFSA\/ACC\/AHA Statement Addresses Concerns Re: Using RAAS Antagonists in COVID-19","volume":"26","author":"Bozkurt","year":"2020","journal-title":"J. Card. Fail."},{"key":"ref_98","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1080\/08998280.2018.1499293","article-title":"Impact of angiotensin-converting enzyme inhibitors and statins on viral pneumonia","volume":"31","author":"Henry","year":"2018","journal-title":"Bayl. Univ. Med. Cent. Proc."},{"key":"ref_99","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/HYPERTENSIONAHA.120.15143","article-title":"Effects of ARBs and ACEIs on Virus Infection, Inflammatory Status and Clinical Outcomes in COVID-19 Patients with Hypertension: A Single Center Retrospective Study","volume":"76","author":"Yang","year":"2020","journal-title":"Hypertension"},{"key":"ref_100","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1080\/22221751.2020.1746200","article-title":"Renin-angiotensin system inhibitors improve the clinical outcomes of COVID-19 patients with hypertension","volume":"9","author":"Meng","year":"2020","journal-title":"Emerg. Microbes Infect."},{"key":"ref_101","doi-asserted-by":"crossref","first-page":"19840","DOI":"10.1038\/srep19840","article-title":"Angiotensin-converting enzyme 2 inhibits lung injury induced by respiratory syncytial virus","volume":"6","author":"Gu","year":"2016","journal-title":"Sci. Rep."},{"key":"ref_102","doi-asserted-by":"crossref","first-page":"L178","DOI":"10.1152\/ajplung.00009.2008","article-title":"Angiotensin converting enzyme-2 is protective but downregulated in human and experimental lung fibrosis","volume":"295","author":"Li","year":"2008","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_103","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1007\/s11427-020-1643-8","article-title":"Clinical and biochemical indexes from 2019-nCoV infected patients linked to viral loads and lung injury","volume":"63","author":"Liu","year":"2020","journal-title":"Sci. China Life Sci."},{"key":"ref_104","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1111\/j.1365-2362.2009.02153.x","article-title":"SARS-coronavirus modulation of myocardial ACE2 expression and inflammation in patients with SARS","volume":"39","author":"Oudit","year":"2009","journal-title":"Eur. J. Clin. Investig."},{"key":"ref_105","doi-asserted-by":"crossref","first-page":"m810","DOI":"10.1136\/bmj.m810","article-title":"Preventing a covid-19 pandemic","volume":"368","author":"Watkins","year":"2020","journal-title":"BMJ"},{"key":"ref_106","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1161\/01.HYP.0000124667.34652.1a","article-title":"Upregulation of Angiotensin-Converting Enzyme 2 After Myocardial Infarction by Blockade of Angiotensin II Receptors","volume":"43","author":"Ishiyama","year":"2004","journal-title":"Hypertension"},{"key":"ref_107","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.jacc.2008.02.088","article-title":"Detection of Soluble Angiotensin-Converting Enzyme 2 in Heart Failure: Insights Into the Endogenous Counter-Regulatory Pathway of the Renin-Angiotensin-Aldosterone System","volume":"52","author":"Epelman","year":"2008","journal-title":"J. Am. Coll. Cardiol."},{"key":"ref_108","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1093\/ajh\/hpu086","article-title":"Urinary Angiotensin-Converting Enzyme 2 in Hypertensive Patients May Be Increased by Olmesartan, an Angiotensin II Receptor Blocker","volume":"28","author":"Furuhashi","year":"2015","journal-title":"Am. J. Hypertens."},{"key":"ref_109","doi-asserted-by":"crossref","first-page":"185","DOI":"10.4070\/kcj.2009.39.5.185","article-title":"Effect of Angiotensin Converting Enzyme Inhibitors and Angiotensin Receptor Blockers on Patients Following Ablation of Atrial Fibrillation","volume":"39","author":"Park","year":"2009","journal-title":"Korean Circ. J."},{"key":"ref_110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1002\/path.1670","article-title":"Renal ACE2 expression in human kidney disease","volume":"204","author":"Lely","year":"2004","journal-title":"J. Pathol."},{"key":"ref_111","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehi275","article-title":"Myocardial infarction increases ACE2 expression in rat and humans: Reply","volume":"26","author":"Burrell","year":"2005","journal-title":"Eur. Heart J."},{"key":"ref_112","doi-asserted-by":"crossref","first-page":"25","DOI":"10.33549\/physiolres.932861","article-title":"Intrapulmonary Activation of the Angiotensin-Converting Enzyme Type 2\/Angiotensin 1\u20137\/G-Protein-Coupled Mas Receptor Axis Attenuates Pulmonary Hypertension in Ren-2 Transgenic Rats Exposed to Chronic Hypoxia","volume":"64","author":"Hampl","year":"2015","journal-title":"Physiol. Res."},{"key":"ref_113","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.RES.67.3.722","article-title":"Peripheral Chemoreceptor Control of Fetal Renin Re-Sponses to Hypoxia and Hypercapnia","volume":"67","author":"Wood","year":"1990","journal-title":"Circ. Res."},{"key":"ref_114","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1161\/01.RES.82.6.722","article-title":"Response of Intra-acinar Pulmonary Microvessels to Hypoxia, Hypercapnic Acidosis, and Isocapnic Acidosis","volume":"82","author":"Yamaguchi","year":"1998","journal-title":"Circ. Res."},{"key":"ref_115","first-page":"1145","article-title":"Cyclooxygenase Mediates Cardioprotection of Angiotensin-(1\u20137) against Ische-Mia\/Reperfusion-Induced Injury through the Inhibition of Oxidative Stress","volume":"4","author":"Liao","year":"2011","journal-title":"Mol. Med. Rep."},{"key":"ref_116","doi-asserted-by":"crossref","unstructured":"Zamai, L. (2020). The Yin and Yang of ACE\/ACE2 Pathways: The Rationale for the Use of Renin-Angiotensin System Inhibitors in COVID-19 Patients. Cells, 9.","DOI":"10.3390\/cells9071704"},{"key":"ref_117","doi-asserted-by":"crossref","first-page":"2453","DOI":"10.1210\/en.2006-1287","article-title":"Synergistic Expression of Angiotensin-Converting Enzyme (ACE) and ACE2 in Human Renal Tissue and Confounding Effects of Hypertension on the ACE to ACE2 Ratio","volume":"148","author":"Wakahara","year":"2007","journal-title":"Endocrinology"},{"key":"ref_118","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1152\/ajplung.00071.2009","article-title":"Ectodomain Shedding of Angiotensin Converting Enzyme 2 in Hu-Man Airway Epithelia","volume":"297","author":"Jia","year":"2009","journal-title":"Am. J. Physiol. Cell. Mol. Physiol."},{"key":"ref_119","doi-asserted-by":"crossref","first-page":"7809","DOI":"10.1073\/pnas.0711241105","article-title":"Modulation of TNF-\u03b1-Converting Enzyme by the Spike Protein of SARS-CoV and ACE2 Induces TNF-\u03b1 Production and Facilitates Viral Entry","volume":"105","author":"Haga","year":"2008","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"ref_120","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1042\/CS20130291","article-title":"Epigenetic Regulation of Angioten-Sin-Converting Enzyme 2 (ACE2) by SIRT1 under Conditions of Cell Energy Stress","volume":"126","author":"Clarke","year":"2013","journal-title":"Clin. Sci."},{"key":"ref_121","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"ref_122","doi-asserted-by":"crossref","first-page":"54","DOI":"10.4103\/0250-474X.180251","article-title":"CoMFA, CoMSIA, HQSAR and molecular docking analysis of ionone-based chalcone derivatives as antiprostate cancer activity","volume":"78","author":"Sharma","year":"2016","journal-title":"Indian J. Pharm. Sci."},{"key":"ref_123","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.3390\/ijms12031605","article-title":"Combined 3D-QSAR Modeling and Molecular Docking Studies on Pyrrole-Indolin-2-ones as Aurora A Kinase Inhibitors","volume":"12","author":"Ai","year":"2011","journal-title":"Int. J. Mol. Sci."},{"key":"ref_124","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ejmech.2010.10.017","article-title":"Molecular modeling studies on imidazo [4, 5-b] pyridine derivatives as Aurora A kinase inhibitors using 3D-QSAR and docking approaches","volume":"46","author":"Lan","year":"2011","journal-title":"Eur. J. Med. Chem."},{"key":"ref_125","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/nm0603-685","article-title":"Molecular regulation of vessel maturation","volume":"9","author":"Jain","year":"2003","journal-title":"Nat. Med."},{"key":"ref_126","unstructured":"Schrodinger LLC (2015). Version 1.8, The PyMOL Molecular Graphics System, Schr\u00f6dinger LLC. Technical Report."},{"key":"ref_127","unstructured":"(2021, October 14). PDBeFold\u2014Structure Similarity, Embl-Ebi. Available online: http:\/\/www.ebi.ac.uk\/msd-srv\/ssm\/cgi-bin\/ssmserver."},{"key":"ref_128","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1021\/jm0203783","article-title":"Comparative Evaluation of 11 Scoring Functions for Molecular Docking","volume":"46","author":"Wang","year":"2003","journal-title":"J. Med. Chem."}],"container-title":["International Journal of Molecular Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11662\/pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,11]],"date-time":"2025-10-11T07:21:54Z","timestamp":1760167314000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.mdpi.com\/1422-0067\/22\/21\/11662"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,10,28]]},"references-count":128,"journal-issue":{"issue":"21","published-online":{"date-parts":[[2021,11]]}},"alternative-id":["ijms222111662"],"URL":"https:\/\/doi.org\/10.3390\/ijms222111662","relation":{},"ISSN":["1422-0067"],"issn-type":[{"type":"electronic","value":"1422-0067"}],"subject":[],"published":{"date-parts":[[2021,10,28]]}}}